CNSP icon

CNS Pharmaceuticals
CNSP

Overview Fund Trends Analyst Outlook Journalist POV

2 hedge funds and large institutions have $228K invested in CNS Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$223K
2
+$4.15K

Top Sellers

1
-$171K
2
-$34K
3
-$33K
4
SAF
Smith Anglin Financial
Texas
-$32.7K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$21.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$223K
2
$4.15K
3
$182
4
$6
5
$3
6
$3
7
$2
8
$2
9
$2
10
$2
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–